Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood (Q73298246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Eidenschink AB

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Schröter G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Müller-Weihrich S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Stern H

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Cardiology in the Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

610-617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

31P NMR spectroscopy in chronic adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

A new insight into adriamycin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Detection of antineoplastic agent induced cardiotoxicity by 31P NMR of perfused rat hearts

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Assessing anthracycline cardiotoxicity in the 1990s

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31P-NMR and implications for adriamycin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951100008891

7 January 2021

10.1017/S1047951100008891

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11117394%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference